Global Immune-Mediated Inflammatory Diseases Treatment Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Immune-Mediated Inflammatory Diseases Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Immune-Mediated Inflammatory Diseases Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Immune-Mediated Inflammatory Diseases Treatment market. Immune-Mediated Inflammatory Diseases Treatment are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Immune-Mediated Inflammatory Diseases Treatment. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Immune-Mediated Inflammatory Diseases Treatment market.
Immune-Mediated Inflammatory Diseases Treatment is any of a group of conditions or diseases that lack a definitive etiology, but which are characterized by common inflammatory pathways leading to inflammation, and which may result from, or be triggered by, a dysregulation of the normal immune response.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Immune-Mediated Inflammatory Diseases Treatment market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Immune-Mediated Inflammatory Diseases Treatment market. It may include historical data, market segmentation by Type (e.g., Targeted biologic therapies, Novel therapies), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Immune-Mediated Inflammatory Diseases Treatment market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Immune-Mediated Inflammatory Diseases Treatment market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Immune-Mediated Inflammatory Diseases Treatment industry. This include advancements in Immune-Mediated Inflammatory Diseases Treatment technology, Immune-Mediated Inflammatory Diseases Treatment new entrants, Immune-Mediated Inflammatory Diseases Treatment new investment, and other innovations that are shaping the future of Immune-Mediated Inflammatory Diseases Treatment.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Immune-Mediated Inflammatory Diseases Treatment market. It includes factors influencing customer ' purchasing decisions, preferences for Immune-Mediated Inflammatory Diseases Treatment product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Immune-Mediated Inflammatory Diseases Treatment market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Immune-Mediated Inflammatory Diseases Treatment market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Immune-Mediated Inflammatory Diseases Treatment market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Immune-Mediated Inflammatory Diseases Treatment industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Immune-Mediated Inflammatory Diseases Treatment market.
Market Segmentation:
Immune-Mediated Inflammatory Diseases Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Immune-Mediated Inflammatory Diseases Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Immune-Mediated Inflammatory Diseases Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Immune-Mediated Inflammatory Diseases Treatment market. Immune-Mediated Inflammatory Diseases Treatment are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Immune-Mediated Inflammatory Diseases Treatment. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Immune-Mediated Inflammatory Diseases Treatment market.
Immune-Mediated Inflammatory Diseases Treatment is any of a group of conditions or diseases that lack a definitive etiology, but which are characterized by common inflammatory pathways leading to inflammation, and which may result from, or be triggered by, a dysregulation of the normal immune response.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Immune-Mediated Inflammatory Diseases Treatment market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Immune-Mediated Inflammatory Diseases Treatment market. It may include historical data, market segmentation by Type (e.g., Targeted biologic therapies, Novel therapies), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Immune-Mediated Inflammatory Diseases Treatment market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Immune-Mediated Inflammatory Diseases Treatment market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Immune-Mediated Inflammatory Diseases Treatment industry. This include advancements in Immune-Mediated Inflammatory Diseases Treatment technology, Immune-Mediated Inflammatory Diseases Treatment new entrants, Immune-Mediated Inflammatory Diseases Treatment new investment, and other innovations that are shaping the future of Immune-Mediated Inflammatory Diseases Treatment.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Immune-Mediated Inflammatory Diseases Treatment market. It includes factors influencing customer ' purchasing decisions, preferences for Immune-Mediated Inflammatory Diseases Treatment product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Immune-Mediated Inflammatory Diseases Treatment market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Immune-Mediated Inflammatory Diseases Treatment market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Immune-Mediated Inflammatory Diseases Treatment market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Immune-Mediated Inflammatory Diseases Treatment industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Immune-Mediated Inflammatory Diseases Treatment market.
Market Segmentation:
Immune-Mediated Inflammatory Diseases Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Targeted biologic therapies
- Novel therapies
- Hospitals
- Pharmacy Store
- Online Pharmacy Stroe
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GlaxoSmithKline
- Eli Lilly
- AstraZeneca
- Bristol-Myers
- Sanofi
- Roche
- Enlivex Therapeutics
- Immune Pharmaceuticals
- Tanabe Pharma
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Size 2019-2030
2.1.2 Immune-Mediated Inflammatory Diseases Treatment Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Immune-Mediated Inflammatory Diseases Treatment Segment by Type
2.2.1 Targeted biologic therapies
2.2.2 Novel therapies
2.3 Immune-Mediated Inflammatory Diseases Treatment Market Size by Type
2.3.1 Immune-Mediated Inflammatory Diseases Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Type (2019-2024)
2.4 Immune-Mediated Inflammatory Diseases Treatment Segment by Application
2.4.1 Hospitals
2.4.2 Pharmacy Store
2.4.3 Online Pharmacy Stroe
2.5 Immune-Mediated Inflammatory Diseases Treatment Market Size by Application
2.5.1 Immune-Mediated Inflammatory Diseases Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Application (2019-2024)
3 IMMUNE-MEDIATED INFLAMMATORY DISEASES TREATMENT MARKET SIZE BY PLAYER
3.1 Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Players
3.1.1 Global Immune-Mediated Inflammatory Diseases Treatment Revenue by Players (2019-2024)
3.1.2 Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Immune-Mediated Inflammatory Diseases Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 IMMUNE-MEDIATED INFLAMMATORY DISEASES TREATMENT BY REGIONS
4.1 Immune-Mediated Inflammatory Diseases Treatment Market Size by Regions (2019-2024)
4.2 Americas Immune-Mediated Inflammatory Diseases Treatment Market Size Growth (2019-2024)
4.3 APAC Immune-Mediated Inflammatory Diseases Treatment Market Size Growth (2019-2024)
4.4 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size Growth (2019-2024)
4.5 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2019-2024)
5.2 Americas Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2019-2024)
5.3 Americas Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2019-2024)
6.2 APAC Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2019-2024)
6.3 APAC Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Immune-Mediated Inflammatory Diseases Treatment by Country (2019-2024)
7.2 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2019-2024)
7.3 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment by Region (2019-2024)
8.2 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2019-2024)
8.3 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL IMMUNE-MEDIATED INFLAMMATORY DISEASES TREATMENT MARKET FORECAST
10.1 Global Immune-Mediated Inflammatory Diseases Treatment Forecast by Regions (2025-2030)
10.1.1 Global Immune-Mediated Inflammatory Diseases Treatment Forecast by Regions (2025-2030)
10.1.2 Americas Immune-Mediated Inflammatory Diseases Treatment Forecast
10.1.3 APAC Immune-Mediated Inflammatory Diseases Treatment Forecast
10.1.4 Europe Immune-Mediated Inflammatory Diseases Treatment Forecast
10.1.5 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Forecast
10.2 Americas Immune-Mediated Inflammatory Diseases Treatment Forecast by Country (2025-2030)
10.2.1 United States Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.2.2 Canada Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.2.3 Mexico Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.2.4 Brazil Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.3 APAC Immune-Mediated Inflammatory Diseases Treatment Forecast by Region (2025-2030)
10.3.1 China Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.3.2 Japan Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.3.3 Korea Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.3.4 Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.3.5 India Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.3.6 Australia Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.4 Europe Immune-Mediated Inflammatory Diseases Treatment Forecast by Country (2025-2030)
10.4.1 Germany Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.4.2 France Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.4.3 UK Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.4.4 Italy Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.4.5 Russia Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.5 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Forecast by Region (2025-2030)
10.5.1 Egypt Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.5.2 South Africa Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.5.3 Israel Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.5.4 Turkey Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.5.5 GCC Countries Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.6 Global Immune-Mediated Inflammatory Diseases Treatment Forecast by Type (2025-2030)
10.7 Global Immune-Mediated Inflammatory Diseases Treatment Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Information
11.1.2 GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Product Offered
11.1.3 GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 GlaxoSmithKline Main Business Overview
11.1.5 GlaxoSmithKline Latest Developments
11.2 Eli Lilly
11.2.1 Eli Lilly Company Information
11.2.2 Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Product Offered
11.2.3 Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Eli Lilly Main Business Overview
11.2.5 Eli Lilly Latest Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Information
11.3.2 AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Product Offered
11.3.3 AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 AstraZeneca Main Business Overview
11.3.5 AstraZeneca Latest Developments
11.4 Bristol-Myers
11.4.1 Bristol-Myers Company Information
11.4.2 Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Product Offered
11.4.3 Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Bristol-Myers Main Business Overview
11.4.5 Bristol-Myers Latest Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi Immune-Mediated Inflammatory Diseases Treatment Product Offered
11.5.3 Sanofi Immune-Mediated Inflammatory Diseases Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Sanofi Main Business Overview
11.5.5 Sanofi Latest Developments
11.6 Roche
11.6.1 Roche Company Information
11.6.2 Roche Immune-Mediated Inflammatory Diseases Treatment Product Offered
11.6.3 Roche Immune-Mediated Inflammatory Diseases Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Roche Main Business Overview
11.6.5 Roche Latest Developments
11.7 Enlivex Therapeutics
11.7.1 Enlivex Therapeutics Company Information
11.7.2 Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Product Offered
11.7.3 Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Enlivex Therapeutics Main Business Overview
11.7.5 Enlivex Therapeutics Latest Developments
11.8 Immune Pharmaceuticals
11.8.1 Immune Pharmaceuticals Company Information
11.8.2 Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Product Offered
11.8.3 Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Immune Pharmaceuticals Main Business Overview
11.8.5 Immune Pharmaceuticals Latest Developments
11.9 Tanabe Pharma
11.9.1 Tanabe Pharma Company Information
11.9.2 Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Product Offered
11.9.3 Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Tanabe Pharma Main Business Overview
11.9.5 Tanabe Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Size 2019-2030
2.1.2 Immune-Mediated Inflammatory Diseases Treatment Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Immune-Mediated Inflammatory Diseases Treatment Segment by Type
2.2.1 Targeted biologic therapies
2.2.2 Novel therapies
2.3 Immune-Mediated Inflammatory Diseases Treatment Market Size by Type
2.3.1 Immune-Mediated Inflammatory Diseases Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Type (2019-2024)
2.4 Immune-Mediated Inflammatory Diseases Treatment Segment by Application
2.4.1 Hospitals
2.4.2 Pharmacy Store
2.4.3 Online Pharmacy Stroe
2.5 Immune-Mediated Inflammatory Diseases Treatment Market Size by Application
2.5.1 Immune-Mediated Inflammatory Diseases Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Application (2019-2024)
3 IMMUNE-MEDIATED INFLAMMATORY DISEASES TREATMENT MARKET SIZE BY PLAYER
3.1 Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Players
3.1.1 Global Immune-Mediated Inflammatory Diseases Treatment Revenue by Players (2019-2024)
3.1.2 Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Immune-Mediated Inflammatory Diseases Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 IMMUNE-MEDIATED INFLAMMATORY DISEASES TREATMENT BY REGIONS
4.1 Immune-Mediated Inflammatory Diseases Treatment Market Size by Regions (2019-2024)
4.2 Americas Immune-Mediated Inflammatory Diseases Treatment Market Size Growth (2019-2024)
4.3 APAC Immune-Mediated Inflammatory Diseases Treatment Market Size Growth (2019-2024)
4.4 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size Growth (2019-2024)
4.5 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2019-2024)
5.2 Americas Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2019-2024)
5.3 Americas Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2019-2024)
6.2 APAC Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2019-2024)
6.3 APAC Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Immune-Mediated Inflammatory Diseases Treatment by Country (2019-2024)
7.2 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2019-2024)
7.3 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment by Region (2019-2024)
8.2 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2019-2024)
8.3 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL IMMUNE-MEDIATED INFLAMMATORY DISEASES TREATMENT MARKET FORECAST
10.1 Global Immune-Mediated Inflammatory Diseases Treatment Forecast by Regions (2025-2030)
10.1.1 Global Immune-Mediated Inflammatory Diseases Treatment Forecast by Regions (2025-2030)
10.1.2 Americas Immune-Mediated Inflammatory Diseases Treatment Forecast
10.1.3 APAC Immune-Mediated Inflammatory Diseases Treatment Forecast
10.1.4 Europe Immune-Mediated Inflammatory Diseases Treatment Forecast
10.1.5 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Forecast
10.2 Americas Immune-Mediated Inflammatory Diseases Treatment Forecast by Country (2025-2030)
10.2.1 United States Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.2.2 Canada Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.2.3 Mexico Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.2.4 Brazil Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.3 APAC Immune-Mediated Inflammatory Diseases Treatment Forecast by Region (2025-2030)
10.3.1 China Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.3.2 Japan Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.3.3 Korea Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.3.4 Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.3.5 India Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.3.6 Australia Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.4 Europe Immune-Mediated Inflammatory Diseases Treatment Forecast by Country (2025-2030)
10.4.1 Germany Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.4.2 France Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.4.3 UK Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.4.4 Italy Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.4.5 Russia Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.5 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Forecast by Region (2025-2030)
10.5.1 Egypt Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.5.2 South Africa Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.5.3 Israel Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.5.4 Turkey Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.5.5 GCC Countries Immune-Mediated Inflammatory Diseases Treatment Market Forecast
10.6 Global Immune-Mediated Inflammatory Diseases Treatment Forecast by Type (2025-2030)
10.7 Global Immune-Mediated Inflammatory Diseases Treatment Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Information
11.1.2 GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Product Offered
11.1.3 GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 GlaxoSmithKline Main Business Overview
11.1.5 GlaxoSmithKline Latest Developments
11.2 Eli Lilly
11.2.1 Eli Lilly Company Information
11.2.2 Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Product Offered
11.2.3 Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Eli Lilly Main Business Overview
11.2.5 Eli Lilly Latest Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Information
11.3.2 AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Product Offered
11.3.3 AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 AstraZeneca Main Business Overview
11.3.5 AstraZeneca Latest Developments
11.4 Bristol-Myers
11.4.1 Bristol-Myers Company Information
11.4.2 Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Product Offered
11.4.3 Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Bristol-Myers Main Business Overview
11.4.5 Bristol-Myers Latest Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi Immune-Mediated Inflammatory Diseases Treatment Product Offered
11.5.3 Sanofi Immune-Mediated Inflammatory Diseases Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Sanofi Main Business Overview
11.5.5 Sanofi Latest Developments
11.6 Roche
11.6.1 Roche Company Information
11.6.2 Roche Immune-Mediated Inflammatory Diseases Treatment Product Offered
11.6.3 Roche Immune-Mediated Inflammatory Diseases Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Roche Main Business Overview
11.6.5 Roche Latest Developments
11.7 Enlivex Therapeutics
11.7.1 Enlivex Therapeutics Company Information
11.7.2 Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Product Offered
11.7.3 Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Enlivex Therapeutics Main Business Overview
11.7.5 Enlivex Therapeutics Latest Developments
11.8 Immune Pharmaceuticals
11.8.1 Immune Pharmaceuticals Company Information
11.8.2 Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Product Offered
11.8.3 Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Immune Pharmaceuticals Main Business Overview
11.8.5 Immune Pharmaceuticals Latest Developments
11.9 Tanabe Pharma
11.9.1 Tanabe Pharma Company Information
11.9.2 Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Product Offered
11.9.3 Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Tanabe Pharma Main Business Overview
11.9.5 Tanabe Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Immune-Mediated Inflammatory Diseases Treatment Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Targeted biologic therapies
Table 3. Major Players of Novel therapies
Table 4. Immune-Mediated Inflammatory Diseases Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Type (2019-2024)
Table 7. Immune-Mediated Inflammatory Diseases Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Application (2019-2024)
Table 10. Global Immune-Mediated Inflammatory Diseases Treatment Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Player (2019-2024)
Table 12. Immune-Mediated Inflammatory Diseases Treatment Key Players Head office and Products Offered
Table 13. Immune-Mediated Inflammatory Diseases Treatment Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Regions (2019-2024)
Table 18. Global Immune-Mediated Inflammatory Diseases Treatment Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Country (2019-2024)
Table 22. Americas Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Type (2019-2024)
Table 24. Americas Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Application (2019-2024)
Table 26. APAC Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Region (2019-2024)
Table 28. APAC Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Type (2019-2024)
Table 30. APAC Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Application (2019-2024)
Table 32. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Country (2019-2024)
Table 34. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Type (2019-2024)
Table 36. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Immune-Mediated Inflammatory Diseases Treatment
Table 45. Key Market Challenges & Risks of Immune-Mediated Inflammatory Diseases Treatment
Table 46. Key Industry Trends of Immune-Mediated Inflammatory Diseases Treatment
Table 47. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. GlaxoSmithKline Details, Company Type, Immune-Mediated Inflammatory Diseases Treatment Area Served and Its Competitors
Table 52. GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Product Offered
Table 53. GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. GlaxoSmithKline Main Business
Table 55. GlaxoSmithKline Latest Developments
Table 56. Eli Lilly Details, Company Type, Immune-Mediated Inflammatory Diseases Treatment Area Served and Its Competitors
Table 57. Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Product Offered
Table 58. Eli Lilly Main Business
Table 59. Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Eli Lilly Latest Developments
Table 61. AstraZeneca Details, Company Type, Immune-Mediated Inflammatory Diseases Treatment Area Served and Its Competitors
Table 62. AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Product Offered
Table 63. AstraZeneca Main Business
Table 64. AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. AstraZeneca Latest Developments
Table 66. Bristol-Myers Details, Company Type, Immune-Mediated Inflammatory Diseases Treatment Area Served and Its Competitors
Table 67. Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Product Offered
Table 68. Bristol-Myers Main Business
Table 69. Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Bristol-Myers Latest Developments
Table 71. Sanofi Details, Company Type, Immune-Mediated Inflammatory Diseases Treatment Area Served and Its Competitors
Table 72. Sanofi Immune-Mediated Inflammatory Diseases Treatment Product Offered
Table 73. Sanofi Main Business
Table 74. Sanofi Immune-Mediated Inflammatory Diseases Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Sanofi Latest Developments
Table 76. Roche Details, Company Type, Immune-Mediated Inflammatory Diseases Treatment Area Served and Its Competitors
Table 77. Roche Immune-Mediated Inflammatory Diseases Treatment Product Offered
Table 78. Roche Main Business
Table 79. Roche Immune-Mediated Inflammatory Diseases Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Roche Latest Developments
Table 81. Enlivex Therapeutics Details, Company Type, Immune-Mediated Inflammatory Diseases Treatment Area Served and Its Competitors
Table 82. Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Product Offered
Table 83. Enlivex Therapeutics Main Business
Table 84. Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Enlivex Therapeutics Latest Developments
Table 86. Immune Pharmaceuticals Details, Company Type, Immune-Mediated Inflammatory Diseases Treatment Area Served and Its Competitors
Table 87. Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Product Offered
Table 88. Immune Pharmaceuticals Main Business
Table 89. Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Immune Pharmaceuticals Latest Developments
Table 91. Tanabe Pharma Details, Company Type, Immune-Mediated Inflammatory Diseases Treatment Area Served and Its Competitors
Table 92. Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Product Offered
Table 93. Tanabe Pharma Main Business
Table 94. Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Tanabe Pharma Latest Developments
Table 1. Immune-Mediated Inflammatory Diseases Treatment Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Targeted biologic therapies
Table 3. Major Players of Novel therapies
Table 4. Immune-Mediated Inflammatory Diseases Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Type (2019-2024)
Table 7. Immune-Mediated Inflammatory Diseases Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Application (2019-2024)
Table 10. Global Immune-Mediated Inflammatory Diseases Treatment Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Player (2019-2024)
Table 12. Immune-Mediated Inflammatory Diseases Treatment Key Players Head office and Products Offered
Table 13. Immune-Mediated Inflammatory Diseases Treatment Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Regions (2019-2024)
Table 18. Global Immune-Mediated Inflammatory Diseases Treatment Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Country (2019-2024)
Table 22. Americas Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Type (2019-2024)
Table 24. Americas Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Application (2019-2024)
Table 26. APAC Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Region (2019-2024)
Table 28. APAC Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Type (2019-2024)
Table 30. APAC Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Application (2019-2024)
Table 32. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Country (2019-2024)
Table 34. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Type (2019-2024)
Table 36. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Immune-Mediated Inflammatory Diseases Treatment
Table 45. Key Market Challenges & Risks of Immune-Mediated Inflammatory Diseases Treatment
Table 46. Key Industry Trends of Immune-Mediated Inflammatory Diseases Treatment
Table 47. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. GlaxoSmithKline Details, Company Type, Immune-Mediated Inflammatory Diseases Treatment Area Served and Its Competitors
Table 52. GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Product Offered
Table 53. GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. GlaxoSmithKline Main Business
Table 55. GlaxoSmithKline Latest Developments
Table 56. Eli Lilly Details, Company Type, Immune-Mediated Inflammatory Diseases Treatment Area Served and Its Competitors
Table 57. Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Product Offered
Table 58. Eli Lilly Main Business
Table 59. Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Eli Lilly Latest Developments
Table 61. AstraZeneca Details, Company Type, Immune-Mediated Inflammatory Diseases Treatment Area Served and Its Competitors
Table 62. AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Product Offered
Table 63. AstraZeneca Main Business
Table 64. AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. AstraZeneca Latest Developments
Table 66. Bristol-Myers Details, Company Type, Immune-Mediated Inflammatory Diseases Treatment Area Served and Its Competitors
Table 67. Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Product Offered
Table 68. Bristol-Myers Main Business
Table 69. Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Bristol-Myers Latest Developments
Table 71. Sanofi Details, Company Type, Immune-Mediated Inflammatory Diseases Treatment Area Served and Its Competitors
Table 72. Sanofi Immune-Mediated Inflammatory Diseases Treatment Product Offered
Table 73. Sanofi Main Business
Table 74. Sanofi Immune-Mediated Inflammatory Diseases Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Sanofi Latest Developments
Table 76. Roche Details, Company Type, Immune-Mediated Inflammatory Diseases Treatment Area Served and Its Competitors
Table 77. Roche Immune-Mediated Inflammatory Diseases Treatment Product Offered
Table 78. Roche Main Business
Table 79. Roche Immune-Mediated Inflammatory Diseases Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Roche Latest Developments
Table 81. Enlivex Therapeutics Details, Company Type, Immune-Mediated Inflammatory Diseases Treatment Area Served and Its Competitors
Table 82. Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Product Offered
Table 83. Enlivex Therapeutics Main Business
Table 84. Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Enlivex Therapeutics Latest Developments
Table 86. Immune Pharmaceuticals Details, Company Type, Immune-Mediated Inflammatory Diseases Treatment Area Served and Its Competitors
Table 87. Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Product Offered
Table 88. Immune Pharmaceuticals Main Business
Table 89. Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Immune Pharmaceuticals Latest Developments
Table 91. Tanabe Pharma Details, Company Type, Immune-Mediated Inflammatory Diseases Treatment Area Served and Its Competitors
Table 92. Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Product Offered
Table 93. Tanabe Pharma Main Business
Table 94. Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Tanabe Pharma Latest Developments
LIST OF FIGURES
Figure 1. Immune-Mediated Inflammatory Diseases Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Immune-Mediated Inflammatory Diseases Treatment Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Country/Region (2023)
Figure 8. Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Type in 2023
Figure 10. Immune-Mediated Inflammatory Diseases Treatment in Hospitals
Figure 11. Global Immune-Mediated Inflammatory Diseases Treatment Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Immune-Mediated Inflammatory Diseases Treatment in Pharmacy Store
Figure 13. Global Immune-Mediated Inflammatory Diseases Treatment Market: Pharmacy Store (2019-2024) & ($ Millions)
Figure 14. Immune-Mediated Inflammatory Diseases Treatment in Online Pharmacy Stroe
Figure 15. Global Immune-Mediated Inflammatory Diseases Treatment Market: Online Pharmacy Stroe (2019-2024) & ($ Millions)
Figure 16. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Application in 2023
Figure 17. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Player in 2023
Figure 18. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Immune-Mediated Inflammatory Diseases Treatment Market Size 2019-2024 ($ Millions)
Figure 20. APAC Immune-Mediated Inflammatory Diseases Treatment Market Size 2019-2024 ($ Millions)
Figure 21. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size 2019-2024 ($ Millions)
Figure 23. Americas Immune-Mediated Inflammatory Diseases Treatment Value Market Share by Country in 2023
Figure 24. United States Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Region in 2023
Figure 29. APAC Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Type in 2023
Figure 30. APAC Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Application in 2023
Figure 31. China Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Country in 2023
Figure 38. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Type (2019-2024)
Figure 39. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Application (2019-2024)
Figure 40. Germany Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 54. APAC Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 55. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 57. United States Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 58. Canada Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 61. China Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 62. Japan Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 63. Korea Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 65. India Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 66. Australia Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 67. Germany Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 68. France Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 69. UK Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 70. Italy Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 71. Russia Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 72. Spain Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 75. Israel Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 78. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Immune-Mediated Inflammatory Diseases Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Immune-Mediated Inflammatory Diseases Treatment Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Country/Region (2023)
Figure 8. Immune-Mediated Inflammatory Diseases Treatment Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Type in 2023
Figure 10. Immune-Mediated Inflammatory Diseases Treatment in Hospitals
Figure 11. Global Immune-Mediated Inflammatory Diseases Treatment Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Immune-Mediated Inflammatory Diseases Treatment in Pharmacy Store
Figure 13. Global Immune-Mediated Inflammatory Diseases Treatment Market: Pharmacy Store (2019-2024) & ($ Millions)
Figure 14. Immune-Mediated Inflammatory Diseases Treatment in Online Pharmacy Stroe
Figure 15. Global Immune-Mediated Inflammatory Diseases Treatment Market: Online Pharmacy Stroe (2019-2024) & ($ Millions)
Figure 16. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Application in 2023
Figure 17. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Player in 2023
Figure 18. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Immune-Mediated Inflammatory Diseases Treatment Market Size 2019-2024 ($ Millions)
Figure 20. APAC Immune-Mediated Inflammatory Diseases Treatment Market Size 2019-2024 ($ Millions)
Figure 21. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size 2019-2024 ($ Millions)
Figure 23. Americas Immune-Mediated Inflammatory Diseases Treatment Value Market Share by Country in 2023
Figure 24. United States Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Region in 2023
Figure 29. APAC Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Type in 2023
Figure 30. APAC Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Application in 2023
Figure 31. China Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Country in 2023
Figure 38. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Type (2019-2024)
Figure 39. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Application (2019-2024)
Figure 40. Germany Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Immune-Mediated Inflammatory Diseases Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 54. APAC Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 55. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 57. United States Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 58. Canada Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 61. China Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 62. Japan Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 63. Korea Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 65. India Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 66. Australia Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 67. Germany Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 68. France Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 69. UK Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 70. Italy Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 71. Russia Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 72. Spain Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 75. Israel Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Immune-Mediated Inflammatory Diseases Treatment Market Size 2025-2030 ($ Millions)
Figure 78. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share Forecast by Application (2025-2030)
